Curaleaf Holdings, Inc. Securities Litigation

If you purchased a significant amount of shares of CURALEAF HLDGS INC (US TRADING VENUE: CURLF), you have certain options. Investors should contact us.

 

Lawsuit Overview

Defendant:CURALEAF HLDGS INC
Date Filed:August 5th, 2019

According to the Complaint, Curaleaf purports to operate as an integrated medical and wellness cannabis operator in the United States.

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Curaleaf, on its website and social media pages, marketed its CBD products to be used as drugs and dietary supplements, contrary to law; (2) Curaleaf also sold unapproved animal drugs on its website; (3) such conduct would result in a warning letter from the U.S. Food and Drug Administration ("FDA"); and (4) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Sign up for free to create a personalized portfolio with tracking and e-mail alerts for CURALEAF HLDGS INC

 
First Identified Complaint

Michael Skibbe, et al. v. Curaleaf Holdings, Inc., et al.

Date Filed:August 5th, 2019
Class Period Start:November 21st, 2018
Class Period End:July 22nd, 2019
First Identified Complaint Filings
#Document TitleFiling Date
 
First Identified Complaint

Michael Skibbe, et al. v. Curaleaf Holdings, Inc., et al.

Date Filed:August 5th, 2019
Class Period Start:November 21st, 2018
Class Period End:July 22nd, 2019
First Identified Complaint Filings
#Document TitleFiling Date